Recon Top Stories Onkos Surgical® expands access to NanoCept® Antibacterial Technology for patients requiring total femoral replacement byTim AllenSeptember 17, 2026
Regulatory Onkos Surgical® Receives FDA 510(k) Clearance for Application of NanoCept® Antibacterial Technology to Titanium Implants in the ELEOS™ Limb Salvage System byTim AllenJune 9, 2026
Recon Onkos Surgical® Announces Initiation of 522 Post-Market Surveillance Study of the ELEOS™ Limb Salvage System with NanoCept® Antibacterial Implant Technology byTim AllenFebruary 12, 2026
